Objective: We sought to determine the association of dietary factors and risk of cognitive decline in a population at high risk of cardiovascular disease.
Diet is reported to be a potential risk factor for noncommunicable diseases including cardiovascular (CV) disease, Alzheimer disease, and vascular cognitive impairment. Dietary intake may modify the risk of cognitive decline through multiple mechanisms including increased risk of stroke (both overt and covert) and through deficiency of nutrients required for neuronal regeneration (e.g., group B vitamins, and vitamin C). 1 However, the association between overall diet quality and cognitive impairment is uncertain. Although some cohort studies did not report any association between a Mediterranean-style diet and cognitive decline, [2] [3] [4] others reported that adherence to a Mediterranean diet is associated with slower cognitive decline. 5, 6 Three recent systematic reviews reported that moderate adherence to a Mediterranean diet is associated with reduced risk of cognitive impairment. [7] [8] [9] In addition, one study reported that a Western diet (vs Oriental diet) was associated with a reduced risk of Alzheimer disease. 10 More precise associations between diet (assessed using standardized methodology) and cognitive outcomes may be observed in a large multinational prospective cohort study. The ONTARGET 11 (Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial) and TRANSCEND 12 (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) studies provide a unique opportunity to investigate the association between diet quality and cognitive decline in a population at high risk of CV disease.
METHODS Study population. We included participants from the ONTARGET and TRANSCEND studies, which were 2 parallel, multinational, double-blind, randomized trials with similar protocols, conducted in 733 centers in 40 middle-and high-income countries. These trials included 31,456 men and women aged 55 years and older with a history of one or more of coronary, cerebral, or peripheral artery disease, or high-risk diabetes mellitus. Neither ONTARGET nor TRANSCEND included patients with acute coronary syndrome, acute stroke, congestive heart failure (CHF), or important renal insufficiency. The primary outcome in both trials was the first occurrence of the composite of CV disease death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for CHF. For ONTARGET, 99.8% of participants, and for TRANSCEND, 99.7% of participants were followed until the first primary outcome or the end of the study. The designs and main findings of both studies have been previously reported. 11, 12 For these analyses, we included only participants who completed a Mini-Mental State Examination (MMSE) at baseline and at least once more during study follow-up. Of 31,456 participants enrolled in the ONTARGET and TRANSCEND trials, 30,959 (98.1%) completed the MMSE at baseline and 90% of these completed the MMSE during follow-up, making 27,860 participants eligible for inclusion in these analyses. The median followup for participants included in these analyses was 4.9 (4.4-5.0) years. We compared the included and excluded participants and found included participants to be slightly younger, more likely to be male, to have normal creatinine, and less likely to have proteinuria (table e-1 on the Neurology ® Web site at Neurology.org).
Data collection, measures, and cognitive assessment. We obtained information at baseline on age, education, fasting lipids, glucose, and lifestyle, including diet, smoking, and alcohol intake. Medications, physical activity, blood pressure, and body mass index (BMI) were recorded at baseline, 2 years, and study end.
Trained members of the study team administered the MMSE at baseline, at 2 years of follow-up, and at the penultimate trial visit (5 years in ONTARGET and 5.5 years in TRANSCEND). The MMSE includes 10 domain items that measure orientation to time (5 points) and place (5 points), registration (3 points), attention and calculation (5 points), recall (3 points), naming and repetition (3 points), comprehension (3 points), reading ability (1 point), writing ability (1 point), and design copy (1 point), the latter being a measure of visual construction. For each successfully completed item on the MMSE, a score of 1 point was awarded for a total score from 0 to 30, with a higher score indicating better cognitive performance.
Outcome measures. Cognitive decline was defined as a decrease of 3 or more points in MMSE score at any time during follow-up, 13, 14 computed by subtracting the score at the last follow-up visit from the baseline score. We defined the outcome of decline in MMSE subdomains based on the maximum possible score for each subdomain. For components with a maximum score of 5, the outcome was defined as a decline of 2 or more points; for those with a maximum score of 3, the outcome was defined as a decline of 1 or more points.
Assessment of diet quality. At baseline, we recorded participants' food intake using a qualitative Food Frequency Questionnaire (FFQ) containing 20 items (table e-2). Despite regional differences, this FFQ is applicable in different countries. 15 The FFQ was administered after patients were checked for compliance with run-in drugs and confirmed eligibility (week 0). Participants were asked, "In the last 12 months, how often did you eat foods from each of the following categories?" for a standard list of food items. For these analyses, frequencies of consumption were converted to "times per day," and the association between diet quality and cognitive decline was determined using the modified Alternative Healthy Eating Index (mAHEI), which was developed to measure overall diet quality. 16 The mAHEI has 7 components comprising the consumption of vegetables, fruits, nuts and soy proteins, whole grain, deep-fried foods, ratio of fish to meat and egg, and alcohol. Cutoff points for scoring were based on dietary recommendations, with a maximum of 10 points assigned when the dietary recommendation was met. A higher score indicates more frequent intake of healthy food choices (e.g., fruits, nuts and soy protein). 16 Covariates. Geographical region was defined as West (including Canada, Mexico, United States, Belgium, Czech Republic, France, Austria, Germany, Greece, Hungary, Italy, the Netherlands, Poland, Portugal, Russia, Denmark, Finland, Norway, Sweden, Slovakia, Spain, Switzerland, United Kingdom, Ireland, Ukraine, Australia, and New Zealand), East (including South Africa, Turkey, United Arab Emirates, China, Hong Kong, Philippines, Singapore, Malaysia, South Korea, Taiwan, and Thailand), and South American (including Argentina and Brazil). Education was categorized as #12 or .12 years and smoking categorized as never, former, or current smoker. Physical activity was self-reported and categorized as sedentary (active less than once per week), moderate (active 2 to 4 times per week), or high (active more than 4 times per week). We defined microalbuminuria as urine albumin to creatinine ratio of 30 to 300 mg/g and macroalbuminuria was defined as albumin to creatinine ratio of .300 mg/g. Antithrombotic use included antiplatelet or anticoagulant agents. Depression was self-reported and defined as either previous treatment for depression or a yes response to the question, "Have you ever had a time when you felt sad, low in your spirits, or depressed for 2 weeks or more in a row?" Statistical analysis. Mean (SD) and medians (range) were calculated to summarize continuous variables and participant characteristics compared using x 2 and analysis of variance tests as appropriate. Cox proportional hazards regression was used to determine the association between diet quality (mAHEI divided into quintiles) and cognitive decline. Multivariable adjustment included continuous (age, BMI, blood pressure, baseline MMSE score) and categorical variables (sex, trial enrollment, treatment allocation, geographical region, education, smoking, physical activity, medical history [stroke/TIA, hypertension, diabetes mellitus, and myocardial infarction], and medication use [statin, b-blocker, antithrombotic]). To account for intraclass correlations within centers, the standard error of coefficients were estimated using the robust sandwich approach. We performed sensitivity analysis to address reverse causation of dietary modification by excluding (1) patients with a major CV event (stroke, myocardial infarction, or hospitalization for CHF) during followup, (2) patients with history of cancer before or during follow-up, (3) patients with baseline MMSE score ,24, and (4) patients with cognitive decline during the first 2 years of follow-up. Furthermore, we explored whether the association between diet quality and the outcome varied between participants categorized by baseline MMSE score (,26 vs 26-28 vs .28) 17 and levels of physical activity at baseline. We also explored whether the association varied using alternative definitions for cognitive decline (alternative definition 1 5 decline $2 points; alternative definition 2 5 decline $4 points). Subgroup analyses were conducted for each component of the MMSE. For all analyses, the criterion for statistical significance was ,0.05. We used SAS version 8.2 for UNIX (SAS Institute, Cary, NC) for all analyses.
Standard protocol approvals, registrations, and patient consents. The local ethics committee in each country approved the study according to local regulations. Both studies were coordinated by the Population Health Research Institute, McMaster University, and Hamilton Health Sciences (Hamilton, Canada); Oxford University, United Kingdom, and University of Auckland, New Zealand. Participants provided consent before enrollment in the study. The study was registered with www.clinicaltrials.gov (NCT00153101).
RESULTS
In 27,860 participants included in these analyses, the median mAHEI score was 24.4 (minimum 3.1, maximum 66.7) and baseline mean (SD) MMSE score was 27.7 (2.8) . Participants with higher mAHEI scores (healthiest diet) were slightly older, more active, less likely to smoke, had a lower BMI, normal serum creatinine, and had higher MMSE score (p , 0.001) (table 1) .
Diet quality and risk of cognitive decline. Cognitive decline occurred in 4,699 participants (16.8%) during follow-up. After multivariable adjustment, we observed an inverse association between diet quality and risk of cognitive decline. Comparing healthiest vs unhealthiest diet, the highest quintile of mAHEI was associated with a reduction in risk of cognitive decline (hazard ratio [HR] 0.76, 95% confidence interval [CI] 0.66-0.86) (figure 1) (p for trend ,0.01).
Sensitivity analyses. The healthiest diet (Q5) continued to be associated with a reduced risk of cognitive decline after excluding those with a major CV event (HR 0.77, 95% CI 0.67-0.89), those with cancer (HR 0.76, 95% CI 0.66-0.88), those with baseline MMSE score ,24 (HR 0.74, 95% CI 0.65-0.85), and those with cognitive decline during the first 2 years (HR 0.65, 95% CI 0.53-0.79). We observed similar associations between categories of baseline MMSE (although a small number of participants had baseline MMSE score ,26) and physical activity (figure 2). The overall pattern of association between mAHEI and cognitive decline was similar using multiple definitions of cognitive decline (figure 3). DISCUSSION To our knowledge, this is the first study to investigate the association between diet quality and cognitive impairment in a large multinational cohort of middle-aged and elderly people at high CV risk. In this large multinational cohort, we report that high diet quality is associated with a lower risk of cognitive decline, after controlling for known confounding factors over 5 years of follow-up. The association persisted after excluding those with major CV events during follow-up, those with cancer, those with MMSE score ,24 at baseline, and those with cognitive decline during the first 2 years of follow-up, and using multiple definitions of cognitive decline.
To date, observational studies evaluating the association between diet quality, or its constituents (high intake of fruit and vegetables, nuts, fish, moderate alcohol intake, and low consumption of red meat), and Diet quality (mAHEI) and cognitive decline Adjusted HR and 95% CIs for the association between quintiles of diet quality (mAHEI) and cognitive decline, where Q1 represents the unhealthiest diet and Q5 the healthiest diet. The primary analyses are presented as the overall cohort; sensitivity analyses are presented excluding early events (first 2 years of follow-up), those with the composite (cardiovascular) outcome from the primary studies, those with baseline MMSE score ,24, and those with cancer at baseline. All HRs adjusted for age, education, sex, trial enrollment (ONTARGET or TRANSCEND), treatment allocation, geographical region, baseline MMSE score, systolic blood pressure, history of stroke/TIA, diabetes mellitus, myocardial infarction, microalbuminuria, macroalbuminuria, serum creatinine, statin therapy, b-blocker therapy, antithrombotic use (antiplatelet or anticoagulant), smoking, body mass index, physical activity, and depression. CI 5 confidence interval; Excl 5 excluding; HR 5 hazard ratio; mAHEI 5 modified Alternative Healthy Eating Index; MMSE 5 Mini-Mental State Examination.
cognitive decline report mixed findings; some report a positive association 18 while others no association. 6, 19, 20 Three recent systematic reviews explored the association between a Mediterranean diet and cognitive impairment and pooled analyses of 8 studies reported that moderate adherence to a Mediterranean diet was associated with a reduced risk of cognitive impairment. 7, 8, 21 Similar to these reports, in this large multinational cohort study of middle-aged and elderly people, we observed a graded independent association between diet quality and cognitive decline. We also report novel information on the association between healthy eating and several subdomains of the MMSE. The mechanism by which a healthy diet may lead to a reduced risk of cognitive decline requires further study. In addition to the established association between healthy diet and a reduction in overt stroke, a healthy diet may also reduce covert stroke (with resultant ischemia from microbleeds), although unproven. Foods rich in omega-3 fatty acids, vitamins C and E, folate, and other carotenoids may alter inflammatory pathways via reductions in oxidative stress and lipid peroxidation. 8 In our cohort of people at high CV risk, the risk of covert stoke was expected to be high, as well as other CV events, such as hospitalization for CHF, that may also increase the risk of cognitive decline. Of note, the association between diet quality and cognitive decline persisted when participants with major CV events during follow-up were excluded. Modifying risk factors for covert stroke such as hypertension, independent of diet quality, could also indirectly modify cognitive decline. For example, diets high in fruits and vegetables, which are rich in potassium, may lower blood pressure and reduce the risks of stroke and cognitive decline. We previously reported that a healthy diet was associated with a reduced risk of recurrent CV events, which lends support to the suggested mechanism in those with established CV disease. 16 In addition, our analyses of MMSE components demonstrate a preferential association with domains that are prominent in vascular cognitive impairment (e.g., executive function).
Our study has several strengths including the large number of patients and outcome events (.4,000), the international cohort, detailed information on covariates, and the high completeness of data (99.8%). The method used to measure diet, the short FFQ, is reported to be a reliable measure of dietary intake by previous studies. 15, 16 Similarly, the method used to measure cognitive function, the MMSE, is a validated and widely used method of cognitive assessment, although it may have poor sensitivity for the detection of mild cognitive impairment, subtle changes in word recall, or impairment in executive function. 22, 23 Our study has a number of limitations. First, because this is an observational study, we can only establish association and not causation, and the effect of residual confounding cannot be ruled out, as dietary habits tend to be lifelong and may be a proxy for other poor health behaviors that were either unknown or unmeasured. Although we adjusted for BMI and physical activity, we chose not to also adjust for energy (caloric) intake because of the effect of multicollinearity and risk of overadjustment. 24 Second, diet quality was measured only at baseline and we were unable to assess change in diet during follow-up. However, significant Adjusted HR (95% CI) for the association between quintiles of diet quality and cognitive decline using 3 definitions of cognitive decline. All HRs adjusted for age, education, sex, trial enrollment (ONTARGET or TRANSCEND), treatment allocation, geographical region, baseline MMSE score, systolic blood pressure, history of stroke/TIA, diabetes mellitus, myocardial infarction, microalbuminuria, macroalbuminuria, serum creatinine, statin therapy, b-blocker therapy, antithrombotic use (antiplatelet or anticoagulant), smoking, BMI, physical activity, and depression. CI 5 confidence interval; HR 5 hazard ratio.
changes in dietary habits would be unlikely to occur over the length of follow-up of this study, including in those with incident CV events. 25 In addition, those with incident CV disease would be more likely to change from unhealthy to healthy dietary patterns during follow-up, which would more likely bias toward the null. Third, our findings may partly be explained by reverse causation, as those at higher disease burden at baseline may be more likely to experience outcomes during follow-up. However, when we excluded participants with early cognitive decline (during the first 2 years of follow-up), the observed associations were materially unchanged. Fourth, dietary assessment by short FFQ in those with cognitive impairment at baseline may not accurately represent diet-disease association because the dietary assessment may not be as reliable and diet quality is unlikely to reverse established cognitive impairment. However, sensitivity analyses, excluding those with MMSE score ,24 at baseline, did not materially alter the observed associations.
In conclusion, we report that higher diet quality is associated with a reduced risk of cognitive decline. Improved diet quality represents an important potential target for reducing the global burden of cognitive decline.
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